{"result": "(\"entity\"<|>HÍGADO<|>GEO<|>The liver is an organ where the GALK1 gene is expressed, playing a crucial role in galactose metabolism.)\n##\n(\"entity\"<|>ERITROCITOS<|>GEO<|>Erythrocytes are red blood cells where the galactokinase activity is measured to diagnose galactokinase deficiency.)\n##\n(\"entity\"<|>LEUCOCITOS<|>GEO<|>Leukocytes are white blood cells that also express the GALK1 gene and are involved in the metabolism of galactose.)\n##\n(\"entity\"<|>FISIOPATOLÓGIA<|>EVENT<|>Pathophysiology refers to the study of the functional changes that occur in the body as a result of galactokinase deficiency.)\n##\n(\"entity\"<|>DIAGNÓSTICO<|>EVENT<|>Diagnosis involves quantifying the activity of galactokinase in erythrocytes and confirming it through genetic testing.)\n##\n(\"relationship\"<|>HÍGADO<|>GALACTOKINASA<|>The liver is one of the primary sites where galactokinase is expressed and functions in galactose metabolism<|>6)\n##\n(\"relationship\"<|>ERITROCITOS<|>GALACTOKINASA<|>Erythrocytes are used to measure galactokinase activity for diagnosing galactokinase deficiency<|>7)\n##\n(\"relationship\"<|>LEUCOCITOS<|>GALACTOKINASA<|>Leukocytes also express the GALK1 gene, contributing to the metabolism of galactose<|>5)\n##\n(\"relationship\"<|>FISIOPATOLÓGIA<|>GALACTOKINASA<|>The pathophysiology of galactokinase deficiency explains the health complications arising from the lack of galactokinase activity<|>8)\n##\n(\"relationship\"<|>DIAGNÓSTICO<|>GALACTOKINASA<|>Diagnosis of galactokinase deficiency is based on the measurement of galactokinase activity in blood cells<|>9)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: azo no está claro dados los pocos casos\n                                                                    publicados, pero parece que se producen compli-\n2.3.    Déficit de galactokinasa                                    caciones similares. Se postula que el déficit de\n                                                                    galactoproteínas y galactolípidos puede estar im-\n2.3.1.     Fisiopatología y diagnóstico                             plicado en la fisiopatología de la enfermedad.\n    El gen de la galactokinasa (GALK1, 17q25.1) se ex-           c. Déficit intermedio: La actividad GALE es deficien-\npresa en el hígado, eritrocitos y leucocitos, y convierte           te en eritrocitos y leucocitos y menor del 50% en\nla galactosa en Gal-1-P. El déficit de GALK se hereda de            el resto de los tejidos. Los individuos están libres\nforma autosómica recesiva y tiene una prevalencia esti-             de las manifestaciones agudas clásicas durante el\nmada de 1:100.000. La galactosa no metabolizada se                  período neonatal, pero no está claro si a largo\nderiva hacia la síntesis de galactonato y galactitol. El            plazo se producen secuelas.\ngalactonato puede ser utilizado para la producción de            Los pacientes con cualquiera de estos tres fenotipos\nenergía (ruta de las pentosas fosfato) y no interviene en     dan positivo en el screening neonatal de galactosemia\nla patogenia de la enfermedad, pero el galactitol se          cuando se cuantifica la galactosa plasmática total o la\nacumula en el cristalino y provoca cataratas sublenticu-      Gal-1-P eritrocitaria, pero se diferencian de la galacto-\nlares en las primeras semanas de vida por efecto osmó-        semia clásica en que la actividad GALT es normal. El\ntico, como en la galactosemia clásica. En cambio, no se       diagnóstico se realiza mediante la cuantificación de la\nproducen complicaciones en otros órganos, y las cata-         actividad GALE, que está disminuida en eritrocitos en\nratas desaparecen con tratamiento dietético adecua-           los tres fenotipos descritos, y también en fibroblastos y\ndo. Los pacientes presentan niveles elevados de galac-        hepatocitos en el déficit generalizado e intermedio. La\ntosa en plasma y de galactitol urinario, y dan positivo       confirmación viene dada por el estudio genético.\nen el    screening    neonatal para galactosemia. El diag-\nnóstico diferencial se realiza mediante la determina-\nción de la actividad GALK en eritrocitos y se confirma        2.4.2.    Objetivos nutricionales y\nmediante estudio genético.                                              recomendaciones dietéticas\n2.3.2.     Objetivos nutricionales y                             Los individuos que presentan la forma periférica no\n           recomendaciones dietéticas                         precisan tratamiento. Los pacientes con la forma gene-\n                                                              ralizada deben seguir una dieta limitada en galactosa,\n    Debe seguirse una dieta sin lácteos de por vida para      aunque no requieren que ésta sea tan estricta como en\nevitar la formación de cataratas. Sin embargo, parece         la galactosemia clásica, ya que la síntesis endógena de\nque los pacientes toleran sin riesgo los alimentos no         este monosacárido está bloqueada. Esto significa evitar\nlácteos que contienen galactosa (legumbres, verduras,         los productos lácteos y sus derivados, pero está permi-\nfrutas, vísceras).                                            tido el consumo de los alimentos no lácteos que con-\n                                                              tienen galactosa (cuya absorción además está cuestio-\n2.4.    Déficit de uridin difosfato                           nada, como vimos en la galactosemia clásica). Los\n        galactosa-4-epimerasa                                 pacientes con la forma intermedia también deben lle-\n                                                              var una dieta limitada en galactosa al menos durante la\n2.4.1.     Fisiopatología y diagnóstico                       lactancia, y dado que no queda claro el pronóstico a\n                                                              largo plazo, en general se suele mantener la restricción\n    La uridin difosfato galactosa-4-epimerasa (GALE) ca-      durante años. No obstante, puede realizarse una prue-\ntaliza el paso de UDP-Gal y Glu-1-P en Gal-1-P y UDP-         ba de liberalización de la dieta durante 2 semanas y\nGlu, así como la reacción inversa para la síntesis endó-      determinar los niveles de Gal-1-P y galactitol urinario\ngena de galactosa y de galactoproteínas y galactolípidos      para decidir si es preciso mantenerla.\n(como los cerebrósidos).\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>GALACTOKINASA<|>EVENT<|>Galactokinase deficiency is a condition that affects the metabolism of galactose, leading to complications such as cataracts and other health issues.)\n##\n(\"entity\"<|>GALK1<|>PERSON<|>GALK1 is a gene located on chromosome 17q25.1 that is responsible for the expression of galactokinase in various tissues including the liver and blood cells.)\n##\n(\"entity\"<|>GALACTOSE<|>PERSON<|>Galactose is a monosaccharide that is metabolized by the body, and its accumulation can lead to health complications in individuals with galactokinase deficiency.)\n##\n(\"entity\"<|>GALACTONATO<|>PERSON<|>Galactonate is a compound that can be produced from non-metabolized galactose and can be used for energy production.)\n##\n(\"entity\"<|>GALACTITOL<|>PERSON<|>Galactitol is a sugar alcohol that accumulates in the lens of the eye in individuals with galactokinase deficiency, leading to cataracts.)\n##\n(\"entity\"<|>CATALECTAS<|>EVENT<|>Cataracts are a common complication in individuals with galactokinase deficiency due to the accumulation of galactitol in the lens of the eye.)\n##\n(\"entity\"<|>DIETA SIN LÁCTEOS<|>EVENT<|>A lifelong dairy-free diet is recommended for individuals with galactokinase deficiency to prevent the formation of cataracts.)\n##\n(\"entity\"<|>SCREENING NEONATAL<|>EVENT<|>Neonatal screening for galactosemia is a test performed to identify infants at risk for galactokinase deficiency.)\n##\n(\"entity\"<|>GENÉTICO<|>EVENT<|>Genetic testing is used to confirm the diagnosis of galactokinase deficiency by studying the GALK gene.)\n##\n(\"relationship\"<|>GALK1<|>GALACTOKINASA<|>GALK1 is the gene responsible for the expression of galactokinase, which is crucial for galactose metabolism<|>8)\n##\n(\"relationship\"<|>GALACTOSE<|>GALACTOKINASA<|>Galactose metabolism is directly affected by the activity of galactokinase, and its deficiency leads to health complications<|>9)\n##\n(\"relationship\"<|>GALACTOKINASA<|>CATALECTAS<|>Cataracts are a complication that arises from the accumulation of galactitol due to galactokinase deficiency<|>7)\n##\n(\"relationship\"<|>GALACTOKINASA<|>DIETA SIN LÁCTEOS<|>A dairy-free diet is recommended to manage the symptoms and prevent complications associated with galactokinase deficiency<|>6)\n##\n(\"relationship\"<|>GALACTOKINASA<|>SCREENING NEONATAL<|>Neonatal screening is performed to detect galactokinase deficiency early in infants<|>5)\n##\n(\"relationship\"<|>GALACTOKINASA<|>GENÉTICO<|>Genetic testing is used to confirm the diagnosis of galactokinase deficiency<|>8)\n##\n(\"relationship\"<|>GALACTONATO<|>GALACTOKINASA<|>Galactonate is produced from non-metabolized galactose, which is a result of galactokinase deficiency<|>4)\n##\n(\"relationship\"<|>GALACTITOL<|>GALACTOKINASA<|>Galactitol accumulates in the lens of the eye due to the lack of galactokinase activity, leading to cataracts<|>7)\n<|COMPLETE|>"}]}